Xiaobin Ma

542 total citations
31 papers, 378 citations indexed

About

Xiaobin Ma is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Xiaobin Ma has authored 31 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Xiaobin Ma's work include Breast Cancer Treatment Studies (6 papers), Ferroptosis and cancer prognosis (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Xiaobin Ma is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Ferroptosis and cancer prognosis (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Xiaobin Ma collaborates with scholars based in China and United States. Xiaobin Ma's co-authors include Huafeng Kang, Min Qian, Bing Du, Shuai Lin, Zhijun Dai, Na Zhang, Ruimei Li, Mingyao Liu, Binghe Tan and Ling Zhao and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Advanced Functional Materials.

In The Last Decade

Xiaobin Ma

27 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobin Ma China 12 155 63 60 57 55 31 378
Rosalind L. Russell United States 11 272 1.8× 33 0.5× 95 1.6× 62 1.1× 24 0.4× 18 454
Jinsen Lu China 13 217 1.4× 15 0.2× 35 0.6× 77 1.4× 113 2.1× 18 445
Shuang Fei China 11 191 1.2× 15 0.2× 58 1.0× 39 0.7× 61 1.1× 25 367
Zhitao Gao China 10 150 1.0× 12 0.2× 133 2.2× 53 0.9× 134 2.4× 25 461
Luocheng Li China 10 154 1.0× 7 0.1× 34 0.6× 77 1.4× 33 0.6× 20 345
Jiayin Yang China 13 142 0.9× 62 1.0× 76 1.3× 43 0.8× 47 0.9× 33 476
Anke Werner Germany 13 122 0.8× 8 0.1× 53 0.9× 61 1.1× 119 2.2× 27 391
Weigang Yuan China 8 273 1.8× 30 0.5× 38 0.6× 126 2.2× 78 1.4× 11 782
Miaojuan Qiu China 13 202 1.3× 7 0.1× 82 1.4× 27 0.5× 30 0.5× 21 425

Countries citing papers authored by Xiaobin Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaobin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Ma more than expected).

Fields of papers citing papers by Xiaobin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Ma. The network helps show where Xiaobin Ma may publish in the future.

Co-authorship network of co-authors of Xiaobin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobin Ma. A scholar is included among the top collaborators of Xiaobin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobin Ma. Xiaobin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lyu, Lijuan, Ming Yi, Jihua Chen, et al.. (2025). Bispecific Antibody Targeting VEGF/TGF‐β Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects. Advanced Science. 12(30). e01819–e01819. 1 indexed citations
2.
3.
Liu, Dandan, Xuyan Zhao, Xueting Ren, et al.. (2024). Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures. Clinical & Translational Oncology. 26(9). 2323–2338.
4.
Liu, Dandan, Qian Hao, Xueting Ren, et al.. (2024). Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancer. Journal of Cancer Research and Clinical Oncology. 150(8). 378–378.
5.
Hao, Qian, Ji Xu, Xin Zhou, et al.. (2024). A Multistage‐Responsive Antibody‐Delivery Strategy to Improve Immunotherapy for NSCLC Brain Metastasis by Ultrasensitive Releasing and Tumor‐Anchoring. Advanced Functional Materials. 34(17). 8 indexed citations
6.
7.
Ren, Xueting, et al.. (2024). PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer. Journal of Cancer Research and Clinical Oncology. 150(3). 119–119. 3 indexed citations
8.
Qu, Haijing, Jinfan Yang, Xin Zhou, et al.. (2023). Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment. Journal of Controlled Release. 357. 274–286. 11 indexed citations
9.
Zhou, Hui, et al.. (2023). Low-density lipoprotein: a versatile nanoscale platform for targeted delivery. Nanoscale Advances. 5(4). 1011–1022. 7 indexed citations
10.
Ren, Xueting, et al.. (2023). Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer. Frontiers in Immunology. 14. 1145552–1145552. 13 indexed citations
11.
Lu, Hongwei, Jinfan Yang, Zhongling Wang, et al.. (2022). On-demand targeting nanotheranostics with stimuli-responsive releasing property to improve delivery efficiency to cancer. Biomaterials. 290. 121852–121852. 22 indexed citations
12.
Ren, Xueting, Nan Wang, Dandan Liu, et al.. (2022). Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer. Cancer Medicine. 11(20). 3886–3901. 16 indexed citations
13.
Zhou, Zhangjian, Shuai Lin, Xin Zhang, et al.. (2022). Prognostic effect of radiotherapy in breast cancer patients underwent immediate reconstruction after mastectomy. Frontiers in Oncology. 12. 1010088–1010088. 4 indexed citations
14.
Ma, Xiaobin, et al.. (2022). A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases. Scientific Reports. 12(1). 437–437. 13 indexed citations
15.
Song, Wan-mei, Yifan Li, Xiaobin Ma, et al.. (2019). Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004–2018. Respiratory Research. 20(1). 223–223. 37 indexed citations
16.
17.
Ma, Xiaobin, Xi-Jing Wang, Meng Wang, et al.. (2016). Impact of the PARP1 rs1136410 and rs3219145 polymorphisms on susceptibility and clinicopathologic features of breast cancer in a Chinese population. Translational Cancer Research. 5(5). 520–528. 1 indexed citations
18.
Dai, Zhijun, Zheng Wang, Xi-Jing Wang, et al.. (2016). Distinct role of the <em>Fas </em>rs1800682 and <em>FasL </em>rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese women. Drug Design Development and Therapy. Volume 10. 2359–2367. 8 indexed citations
19.
Zhang, Chunyan, Congxia Wang, Ling Zhao, et al.. (2016). Ferulic Acid against Cyclophosphamide‐Induced Heart Toxicity in Mice by Inhibiting NF‐κB Pathway. Evidence-based Complementary and Alternative Medicine. 2016(1). 1261270–1261270. 48 indexed citations
20.
Ma, Xiaobin, et al.. (2015). Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy. Chinese Medical Journal. 128(19). 2632–2637. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalind L. Russell Breakdown of academic impact, for papers by Jinsen Lu Breakdown of academic impact, for papers by Shuang Fei Breakdown of academic impact, for papers by Zhitao Gao Breakdown of academic impact, for papers by Luocheng Li Breakdown of academic impact, for papers by Jiayin Yang Breakdown of academic impact, for papers by Anke Werner Breakdown of academic impact, for papers by Weigang Yuan Breakdown of academic impact, for papers by Miaojuan Qiu
Rankless by CCL
2026